The Finance Shelf

Funder directory / Sweden / Venture capital firms

Hadean Ventures

Venture capitalOslo, Swedenhadeanventures.comVerified 9 Nov 2026

Hadean Ventures is a European venture capital fund manager with over EUR 230 million in assets under management. It invests in life sciences, healthcare, and across various sectors and stages to back solutions addressing complex unmet needs.

StagesNot stated
Invests inEurope
Deals recorded22
Fund sizeHadean Ventures is a European venture capital fund manage…quoted from their site

What they invest in

  • Hadean Ventures is a European venture capital fund manager with over EUR 230 million in assets under management. source
  • With a strong foundation and track record in life sciences, the firm invests across sectors and stages, backing solutions that address complex, real-world challenges and unmet needs. source
  • The firm's purpose is to generate strong returns while making a meaningful impact by investing in the future. source

All investments and operations

22 operations
CompanyRoundAmountDateCo-investorsSource
Abliva
Rare Disease, SE
––––Portfolio page
Actithera
Oncology
––––Portfolio page
Alex Therapeutics
Digital Health, SE
––––Portfolio page
ARTHEx Biotech
Rare Disease, ES
––––Portfolio page
Attgeno
Cardiovascular, SE
––––Portfolio page
CardioMech
Medical Device, NO
––––Portfolio page
Cardior Pharmaceuticals––––Portfolio page
Complement Therapeutics
Ophthalmology, DE
––––Portfolio page
Contineum Therapeutics
Neurology, US
––––Portfolio page
Emergence Therapeutics
Oncology
––––Portfolio page
Show all 22 operations
Galecto
Oncology, DK
––––Portfolio page
Gesynta Pharma
Women's health, SE
––––Portfolio page
Kasvu Therapeutics
FI
––––Portfolio page
Neuro Event Labs
Digital Health, FI
––––Portfolio page
Nisonic
Medical Device, NO
––––Portfolio page
Oncoinvent
Oncology, NO
––––Portfolio page
Ribbon Bio
Gene Therapy
––––Portfolio page
SAGA Diagnostics
Diagnostics, SE
––––Portfolio page
SciRhom
Immunology, DE
––––Portfolio page
Step Pharma
Oncology
––––Portfolio page
TargED Biopharmaceuticals
Oncology
––––Portfolio page
Themis Bioscience
AT
––––Portfolio page

Exits

  • Cardior Pharmaceuticals Acquired by Novo Nordisk2024 · Source
  • Themis Bioscience Acquired by MSD2020 · Source

Shown only when an exit is documented by a public source.

Similar funders